###begin article-title 0
###xml 129 133 <span type="species:ncbi:10116">Rats</span>
FOXO1 Plays an Important Role in Enhanced Microvascular Cell Apoptosis and Microvascular Cell Loss in Type 1 and Type 2 Diabetic Rats
###end article-title 0
###begin title 1
OBJECTIVE
###end title 1
###begin p 2
To investigate early events leading to microvascular cell loss in diabetic retinopathy.
###end p 2
###begin title 3
RESEARCH DESIGN AND METHODS
###end title 3
###begin p 4
###xml 185 189 <span type="species:ncbi:10116">rats</span>
###xml 216 220 <span type="species:ncbi:10116">rats</span>
###xml 503 506 <span type="species:ncbi:10116">rat</span>
FOXO1 was tested in vivo by DNA binding activity and by nuclear translocation in microvascular cells in retinal trypsin digests. In vivo studies were undertaken in STZ-induced diabetic rats and Zucker diabetic fatty rats using the tumor necrosis factor (TNF)-specific blocker, pegsunercept, or by inhibiting FOXO1 with RNAi. Microvascular cell apoptosis, formation of pericyte ghosts, and acellular capillaries were measured. Upstream and downstream effects of high-glucose-induced FOXO1 were tested on rat microvascular endothelial cells (RMECs) by small-interfering RNA (siRNA) in vitro.
###end p 4
###begin title 5
RESULTS
###end title 5
###begin p 6
DNA binding or nuclear translocation of FOXO1, which was reduced by TNF inhibition, was elevated in type 1 and type 2 diabetic retinas. Diabetes stimulated microvascular cell apoptosis; pericyte ghost and acellular capillary development was inhibited by FOXO1 siRNA. High glucose in vitro decreased FOXO1 phosphorylation and DNA binding activity and decreased Akt phosphorylation in RMECs. High-glucose-stimulated FOXO1 DNA binding activity was mediated through TNF-alpha and formation of reactive oxygen species (ROS), while inhibitors of TNF and ROS and FOXO1 siRNA reduced high-glucose-enhanced RMEC apoptosis. The caspase-3/7 activity and capacity of high glucose to increase mRNA levels of several genes that regulate RMEC activation and apoptosis were knocked down by FOXO1 siRNA.
###end p 6
###begin title 7
CONCLUSIONS
###end title 7
###begin p 8
###xml 33 36 <span type="species:ncbi:10116">rat</span>
###xml 99 103 <span type="species:ncbi:10116">rats</span>
FOXO1 plays an important role in rat retinal microvascular cell loss in type 1 and type 2 diabetic rats and can be linked to the effect of high glucose on FOXO1 activation.
###end p 8
###begin p 9
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 472 472 472 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6"/>
###xml 472 472 472 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7"/>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
Diabetic retinopathy, the leading cause of vision loss in occupational-age adults (1,2), is characterized by early vascular lesions, including apoptosis of microvascular cells, formation of pericyte ghosts, and the development of acellular capillaries before the onset of clinical complications (3,4). The formation of acellular capillaries eventually leads to hypoxia, setting the stage for proliferative diabetic retinopathy that ultimately results in impaired vision (5-8).
###end p 9
###begin p 10
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 371 371 371 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10"/>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 176 180 <span type="species:ncbi:10116">rats</span>
The loss of critical microvascular cells in the early stages of this complication are not well understood. To investigate this issue, we examined in type 1 and type 2 diabetic rats the role of the transcription factor FOXO1, a forkhead transcription factor that regulates cell death, inhibits cell cycle progression, and modulates differentiation in various cell types (9-11). FOXO1 also has cell-specific effects modulating genes that control gluconeogenesis (12), blood vessel assembly during development (13), muscle wasting (14), and inhibition of adipocyte differentiation (15).
###end p 10
###begin p 11
###xml 127 129 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
We recently showed that diabetes-induced tumor necrosis factor (TNF)-alpha plays an important role in microvascular cell loss (16). We demonstrate here for the first time that diabetes enhances FOXO1 DNA binding activity and nuclear translocation in diabetic retinas through a process that is mediated by TNF. Furthermore, inhibition of FOXO1 by RNAi reduces microvascular cell apoptosis and microvascular cell loss in diabetic retinas in vivo and by high glucose in vitro. These results point to the previously unrecognized role of FOXO1 in promoting apoptosis and loss of microvascular cells in diabetic retinopathy.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin p 13
###xml 442 447 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fa/fa</italic>
###xml 497 498 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 60 64 <span type="species:ncbi:10116">rats</span>
###xml 436 440 <span type="species:ncbi:10116">rats</span>
###xml 597 601 <span type="species:ncbi:10116">rats</span>
###xml 797 801 <span type="species:ncbi:10116">rats</span>
###xml 839 843 <span type="species:ncbi:10116">rats</span>
Type 1 diabetic approximately8-week-old Sprague Dawley (SD) rats (Charles River Laboratories, Wilmington, MA) were injected intraperitoneally with streptozotocin (STZ) (55 mg/kg), and control animals received vehicle (0.05 mol/l citrate buffer). Animals were subcutaneously injected with 1-5 units of NPH insulin as needed to maintain serum glucose levels of approximately300 mg/dl. Type 2 diabetes was studied in Zucker diabetic fatty rats (fa/fa) (ZDF) and genetically matched lean controls (fa/+) (Charles River Laboratories). Unless stated, there were 6 animals per group, except for diabetic rats treated with vehicle alone, which consisted of 12 animals per group. Serum glucose and weight were monitored weekly. Glycosylated hemoglobin was measured (Helena Laboratories, Beaumont, TX) when rats were killed. For short-term studies, rats were killed approximately12 weeks after the onset of diabetes; for long-term studies, they were hyperglycemic for approximately6 months and killed at age 33-34 weeks. All measurements were performed by two blinded examiners.
###end p 13
###begin title 14
Application of inhibitors.
###end title 14
###begin p 15
###xml 233 234 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 283 285 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 190 194 <span type="species:ncbi:10116">rats</span>
###xml 423 427 <span type="species:ncbi:10116">rats</span>
###xml 568 572 <span type="species:ncbi:10116">rats</span>
In short-term studies, FOXO1-specific small-interfering RNA (siRNA) (CCA GCT ATA AAT GCA CAT TTA) or scrambled siRNA (45 pmol in 5 mul sterile water) was intravitreally injected in diabetic rats that were hyperglycemic for 12 weeks (n = 5); they were killed 10 days after injection (17). There is no significant homology between the sequence used for FOXO1 siRNA and other forkhead box proteins. For long-term RNAi in STZ, rats were hyperglycemic for 12 weeks and then given two intravitreal injections of siRNA (45 pmol in 5 mul sterile water) 6 weeks apart. The ZDF rats received one intravitreal injection after 24 weeks of hyperglycemia and killed 10 days later.
###end p 15
###begin p 16
###xml 363 365 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 24 28 <span type="species:ncbi:10116">rats</span>
###xml 209 213 <span type="species:ncbi:10116">rats</span>
In STZ-induced diabetic rats, pegsunercept (peg-TNFR1; 50 mug) (Amgen, Thousand Oaks, CA) was applied by intravitreal injections 6, 12, and 18 weeks after becoming hyperglycemic. Pegsunercept was given to ZDF rats 12 and 18 weeks after becoming hyperglycemic. Pegsunercept is a specific TNF inhibitor consisting of a pegylated recombinant soluble TNF receptor-1 (18). For both groups controls received vehicle (sterile PBS) alone.
###end p 16
###begin title 17
Apoptosis, acellular capillaries, and pericyte ghosts.
###end title 17
###begin p 18
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Retinal trypsin digests (RTDs) were assesed by a fluorometic terminal dUTP nick-end labeling (TUNEL) assay (Promega, San Luis Obispo, CA) and by immunohistochemistry using an antibody specific for activated caspase-3 (Cell Signaling Technology, Danvers, MA). RTDs were permeablized (0.5% Triton X-100) and incubated with blocking agent (Chemicon, Temecula, CA), primary or matched control antibody, and biotinylated secondary antibody and fluorescein avidin (Vector Laboratories, Burlingame, CA). Mounting media contained nuclear stain 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories). The entire specimen was surveyed for TUNEL-positive or caspase-3-positive cells by fluorescence microscopy (original magnification x400). RTDs were stained with periodic acid Schiff (PAS)-hematoxylin (6), and 13-15 fields in the midretina were examined as described (16).
###end p 18
###begin title 19
FOXO1 nuclear translocation.
###end title 19
###begin p 20
FOXO1 nuclear translocation was detected by confocal laser-scanning microscopy (Axiovert-100M; Carl Zeiss). Primary antibody to FOXO1 (Santa Cruz Biotech, Santa Cruz, CA) was detected by a Cy5-tagged secondary antibody and nuclei with propidium iodide. The entire RTD was scanned for nuclear FOXO1-positive microvascular cells examining single and merged images. Matched control IgG was negative, demonstrating specificity (data not shown).
###end p 20
###begin title 21
FOXO1 DNA binding.
###end title 21
###begin p 22
###xml 38 42 <span type="species:ncbi:10116">rats</span>
Nuclear protein from whole retinas of rats that were hyperglycemic for 12 weeks and matched normoglycemic controls was measured using a kit from Pierce Biotechnology (Rockford, IL). FOXO1 DNA binding activity was examined in nuclear extracts with a transcription factor DNA binding kit (Active Motif, Carlsbad, CA).
###end p 22
###begin title 23
Real-time PCR.
###end title 23
###begin p 24
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 32 36 <span type="species:ncbi:10116">rats</span>
###xml 140 144 <span type="species:ncbi:10116">rats</span>
Retinas of STZ-induced diabetic rats, hyperglycemic for 12 weeks with or without pegsunercept for the last 8 weeks, and age-matched control rats (n = 6) were snap frozen (16). Total RNA (RNAeasy Mini Kit; Qiagen, Valencia, CA) was isolated and FOXO1 mRNA levels quantified by real-time PCR using TaqMan primers and probes (Applied Biosystems, Foster City, CA).
###end p 24
###begin title 25
FOXO1 DNA binding and caspase-3/7 activity in vitro.
###end title 25
###begin p 26
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 340 341 340 341 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 181 187 <span type="species:ncbi:9913">bovine</span>
Rat microvascular endothelial cells (RMECs) were isolated, characterized, and cultured as described (17,19) and examined at passages 3-8. Cells were cultured in DMEM plus 10% fetal bovine serum (FBS) and changed to 0.5% FBS at least 24 h before the start of experiments. In some experiments, RMECs were preincubated with 10 mmol/l N-acetyl-l-cysteine (NAC) (Sigma-Aldrich) for 2 h followed by incubation with media supplemented with glucose (25 mmol/l) and NAC as indicated. Nuclear protein was isolated and assayed for FOXO1 DNA binding activity (Active Motif). Cytoplasmic proteins were extracted using a kit from Pierce Biotechnology, and caspase-3/7 activity was measured with a caspase-glo 3/7 kit from Promega (Mannheim, Germany).
###end p 26
###begin title 27
FOXO1 and AKT phosphorylation.
###end title 27
###begin p 28
###xml 90 93 <span type="species:ncbi:10116">rat</span>
###xml 732 743 <span type="species:ncbi:3704">horseradish</span>
RMECs were cultured in 96-well plates in DMEM plus 0.25% FBS, transfected with or without rat FOXO1-specific siRNA (5 nmol/l in HiPerfect transfection reagent), or scrambled siRNA (Qiagen) and then incubated in high-glucose media (25 mmol/l) for 5 days. Some wells were incubated with Akt inhibitor (Calbiochem, Gibbstown, NJ). FOXO1 protein, phosphorylated FOXO1, total AKT protein, and phosphorylated AKT levels were determined by using an in situ detection kit from Active Motif. Cells were incubated in high glucose; fixed with 4% paraformaldehyde; permeablized; and incubated with blocking solution followed by primary antibodies to FOXO1, phosphorylated FOXO1, AKT, phosphorylated AKT, or matched control antibody followed by horseradish peroxidase-conjugated secondary antibody. After addition of colorimetric substrate, optical density was measured at 450 nm and corrected for cell number by crystal violet staining and optical density at 695 nm.
###end p 28
###begin title 29
Apoptosis in vitro.
###end title 29
###begin p 30
###xml 620 622 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
RMECs were cultured in DMEM plus 0.25% FBS and transfected with or without rat FOXO1-specific siRNA (5 nmol/l in HiPerfect transfection reagent) or scrambled siRNA (Qiagen) and then incubated with TNF-alpha (20 ng/ml, 6 h) or media supplemented with glucose or mannitol (25 mmol/l) for 5 days. Some RMECs were incubated with 10 mmol/l of NAC (Sigma-Aldrich) or the caspase-3/7-specific inhibitor (Z-DEVD-FMK; R&D Systems) plus high glucose (25 mmol/l) for 5 days. Apoptosis was measured by enzyme-linked immunosorbent assay (ELISA) measuring cytoplasmic histone-associated DNA (Roche Diagnostics), as we have described (20).
###end p 30
###begin title 31
Focused microarray analysis and real-time PCR validation.
###end title 31
###begin p 32
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Total RNA was isolated (RNAeasy; Qiagen) from primary RMECs transfected with FOXO1 or scrambled siRNA, as described above, and then incubated in standard media or media supplemented with glucose or mannitol (25 mmol/l) for 5 days. Focused microarrays (Oligo GEArray; SuperArray, Bethesda, MD) were carried out as we have described (21), and the spot intensity from chemiluminescent images were analyzed using the GeaSuite array analysis (SuperArray). Spot intensities were normalized with ribosomal protein (L32). A value was considered to be modulated if both the mean and the median intensity level in the experimental group was 1.7-fold higher or lower than that of the mean of the corresponding control. Selected genes were confirmed by real-time PCR (Applied Biosystems). Assays were carried out three times to provide means +/- SE.
###end p 32
###begin title 33
Statistical analysis.
###end title 33
###begin p 34
###xml 222 223 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
For all in vitro assays, experiments were carried out three times to provide means +/- SE. Statistical significance was determined by one-way ANOVA with Tukey's post hoc test for comparisons between multiple groups at the P < 0.05 level.
###end p 34
###begin title 35
RESULTS
###end title 35
###begin p 36
###xml 16 20 <span type="species:ncbi:10116">rats</span>
###xml 110 114 <span type="species:ncbi:10116">rats</span>
###xml 138 142 <span type="species:ncbi:10116">rats</span>
Type 1 diabetic rats had reduced weight and higher glycosylated hemoglobin levels compared with normoglycemic rats, while type 2 diabetic rats weighed more and had higher glycosylated hemoglobin levels compared with normoglycemic littermates (data not shown). Treatment with siRNA or pegsunercept had no effect on these parameters (data not shown).
###end p 36
###begin title 37
Diabetes increased FOXO1 nuclear translocation in microvascular cells in vivo and mediated by TNF-alpha.
###end title 37
###begin p 38
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 614 620 614 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 982 988 982 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1123 1130 1123 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figs. 1</xref>
###xml 1130 1130 1130 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2"/>
###xml 1131 1132 1131 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 1329 1335 1317 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1335 1336 1323 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1383 1389 1371 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1389 1390 1377 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1696 1698 1684 1686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1855 1862 1831 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1269 1273 <span type="species:ncbi:10116">rats</span>
###xml 1377 1381 <span type="species:ncbi:10116">rats</span>
###xml 1420 1424 <span type="species:ncbi:10116">rats</span>
FOXO1 nuclear translocation was examined in retinal trypsin digests (RTDs) containing isolated microvascular cells by laser-scanning confocal microscopy. It reflects the activation status since FOXO1 is rapidly transported to the nuclear compartment in the activated state and upon deactivation is quickly transported out of the nucleus (10,11). Confocal microscopy avoids some of the pitfalls of standard immunofluorescence since the images are taken at a focal plane that bisects the nuclear compartment. An example of a microvascular endothelial cell and pericyte with FOXO1 nuclear translocation is evident in Fig. 1. Microvascular cells that were positive for FOXO1 nuclear translocation typically exhibited increased cytoplasmic expression consistent with an overall increase in expression. Conversely, cells without FOXO1 nuclear translocation typically exhibited only faint FOXO1 immunofluorescence in the cytoplasm, indicating a low basal level of expression as indicated (Fig. 1). Additional images demonstrating the FOXO1 nuclear staining in microvascular cells are shown in the online appendix (online appendix Figs. 1-3 [available at ]). The number of retinal microvascular cells with FOXO1 in the nuclear compartment increased fivefold in type 1 diabetic rats that had been hyperglycemic for approximately6 months (Fig. 1C) and almost fourfold in type 2 diabetic rats (Fig. 1D) compared with normoglycemic rats. The midretinal area was further examined and cells that were positive for FOXO1 nuclear staining based upon the confocal microscopic images were characterized as endothelial cells, pericytes, or undetermined based upon the shape and location of nuclei (as described in (16). FOXO1 nuclear translocation-positive microvascular cells were primarily endothelial cells with an endothelial cell to pericyte ratio of approximately2:1 (Table 1).
###end p 38
###begin p 39
###xml 128 129 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 320 330 304 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper left</italic>
###xml 371 382 355 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper right</italic>
###xml 468 479 452 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower right</italic>
###xml 501 511 485 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower left</italic>
###xml 690 691 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 882 892 854 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper left</italic>
###xml 933 944 905 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper right</italic>
###xml 1030 1041 1002 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower right</italic>
###xml 1063 1073 1035 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower left</italic>
###xml 1244 1245 1216 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1517 1518 1487 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1531 1532 1501 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1795 1796 1763 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1809 1810 1777 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 2187 2188 2153 2154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2201 2202 2167 2168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 2625 2626 2589 2590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2639 2640 2603 2604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 2878 2879 2840 2841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2956 2957 2918 2919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3031 3032 2993 2994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 150 154 <span type="species:ncbi:10116">rats</span>
###xml 242 246 <span type="species:ncbi:10116">rats</span>
###xml 712 716 <span type="species:ncbi:10116">rats</span>
###xml 804 808 <span type="species:ncbi:10116">rats</span>
###xml 1363 1367 <span type="species:ncbi:10116">rats</span>
###xml 1369 1371 <span type="species:ncbi:10116">DM</span>
###xml 1395 1399 <span type="species:ncbi:10116">rats</span>
###xml 1427 1429 <span type="species:ncbi:10116">DM</span>
###xml 1480 1484 <span type="species:ncbi:10116">rats</span>
###xml 1633 1637 <span type="species:ncbi:10116">rats</span>
###xml 1674 1678 <span type="species:ncbi:10116">rats</span>
###xml 1758 1762 <span type="species:ncbi:10116">rats</span>
###xml 1927 1931 <span type="species:ncbi:10116">rats</span>
###xml 1933 1935 <span type="species:ncbi:10116">DM</span>
###xml 2019 2023 <span type="species:ncbi:10116">rats</span>
###xml 2051 2053 <span type="species:ncbi:10116">DM</span>
###xml 2134 2138 <span type="species:ncbi:10116">rats</span>
###xml 2277 2281 <span type="species:ncbi:10116">rats</span>
###xml 2283 2285 <span type="species:ncbi:10116">DM</span>
###xml 2376 2380 <span type="species:ncbi:10116">rats</span>
###xml 2408 2410 <span type="species:ncbi:10116">DM</span>
###xml 2491 2495 <span type="species:ncbi:10116">rats</span>
###xml 2699 2703 <span type="species:ncbi:10116">rats</span>
###xml 2705 2707 <span type="species:ncbi:10116">DM</span>
###xml 2779 2783 <span type="species:ncbi:10116">rats</span>
###xml 3025 3029 <span type="species:ncbi:10116">rats</span>
Diabetes-induced increase in FOXO1 mRNA, DNA binding, and nuclear translocation in the retina is partly dependent on TNF-alpha. A: RTDs from diabetic rats that were hyperglycemic for approximately6 months along with age-matched normoglycemic rats were incubated with antibody to FOXO1 and Cy5-tagged secondary antibody (upper left), counterstained with propidium iodide (upper right), and examined by confocal laser-scanning microscopy. Merged FOXO1/propidium iodide (lower right) and phase-contrast (lower left) images are shown. Arrow points to nuclear FOXO1-positive endothelial cells. Incubation with control antibody revealed no staining (data not shown). Original magnification x400. B: RTDs from diabetic rats that were hyperglycemic for approximately6 months along with age-matched normoglycemic rats were incubated with antibody to FOXO1 and Cy5-tagged secondary antibody (upper left), counterstained with propidium iodide (upper right), and examined by confocal laser-scanning microscopy. Merged FOXO1/propidium iodide (lower right) and phase-contrast (lower left) images are shown. Arrow points to nuclear FOXO1-positive pericytes. Incubation with control antibody revealed no staining (data not shown). Original magnification x400. C: The mean number of cells with clearly identified FOXO1 nuclear translocation was determined in STZ-induced diabetic rats (DM), STZ-induced diabetic rats treated with pegsunercept (DM + Peg), and age-matched normoglycemic control (C) rats. Each value is the mean +/- SE (n = 5/group). D: The mean number of cells with clearly identified FOXO1 nuclear translocation was determined in ZDF rats treated with vehicle alone (D), ZDF rats treated with pegsunercept (D + Peg), and age-matched normoglycemic control (C) rats. Each value is the mean +/- SE (n = 6/group). E: RNA was isolated from whole retinas and mRNA levels of FOXO1 determined by real-time PCR from STZ-induced diabetic rats (DM) that had been hyperglycemic for 12 weeks and treated with vehicle alone, diabetic rats treated with pegsunercept (DM + Peg) for 8 weeks before euthanasia, and age-matched normoglycemic control (C) rats. The data presented is mean fold change +/- SE (n = 6/group). F: Nuclear proteins were isolated from whole retina of STZ-induced diabetic rats (DM) with hyperglycemia of 12 weeks duration treated with vehicle alone, STZ-induced diabetic rats treated with pegsunercept (DM + Peg) for 8 weeks before euthanasia, and age-matched normoglycemic control (C) rats. Nuclear proteins were assayed for FOXO1 DNA binding activity using a transcription factor ELISA. Each value is the mean +/- SE (n = 6/group). G: Nuclear proteins were isolated from whole retinas of ZDF rats (DM) with 12 weeks hyperglycemia and age-matched normoglycemic control (C) rats. Nuclear proteins were assayed for FOXO1 DNA binding activity. Each value is the mean +/- SE (n = 6/group). *Significantly higher in the diabetic than normoglycemic group (P < 0.05). **Significantly less in pegsunercept than vehicle-treated rats (P < 0.05). (Please see  for a high-quality digital representation of this figure.)
###end p 39
###begin p 40
Distribution of cells with FOXO1 nuclear translocation in RTDs
###end p 40
###begin p 41
###xml 289 316 289 316 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">research design and methods</sc>
Data are percent. Midretinal areas in RTDs were scored, and cells with FOXO1 nuclear localization were assessed in confocal laser-scanning microscopic images. Cells were categorized as endothelial cells, pericytes, or undetermined based on the shape and location of nuclei as described in research design and methods.
###end p 41
###begin p 42
###xml 221 227 221 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 258 264 258 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 322 328 322 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 328 329 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 379 385 379 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 471 477 471 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 477 478 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 574 580 574 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 676 682 676 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 682 683 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 88 92 <span type="species:ncbi:10116">rats</span>
###xml 267 271 <span type="species:ncbi:10116">rats</span>
###xml 568 572 <span type="species:ncbi:10116">rats</span>
###xml 670 674 <span type="species:ncbi:10116">rats</span>
To investigate a potential mechanism for diabetes-enhanced FOXO1 nuclear translocation, rats were treated with pegsunercept. TNF inhibition for 12 weeks reduced cells with FOXO1-positive nuclei by 76% in type 1 diabetic (Fig. 1C) and 65% in type 2 diabetic (Fig. 1D) rats. Diabetes increased FOXO1 mRNA more than twofold (Fig. 1E), and pegsunercept reduced it by 64% (P < 0.05) (Fig. 1E). Similarly type 1 diabetes increased FOXO1 DNA binding activity more than twofold (Fig. 1F), and TNF inhibition reduced this increase by 74% (P < 0.05) in the STZ-induced diabetic rats (Fig. 1F). Diabetes also significantly increased FOXO1 DNA binding in retinas of type 2 diabetic rats (Fig. 1G).
###end p 42
###begin title 43
FOXO1 inhibition by RNAi reduces microvascular cell apoptosis in diabetic retinas in vivo.
###end title 43
###begin p 44
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 194 200 194 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 436 437 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 447 453 447 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 66 70 <span type="species:ncbi:10116">rats</span>
###xml 334 338 <span type="species:ncbi:10116">rats</span>
A single intravitreal injection of FOXO1 siRNA 10 days before the rats were killed blocked virtually all of the diabetes-increased FOXO1 mRNA, demonstrating efficacy of RNAi in vivo (P < 0.05) (Fig. 2A). Scrambled siRNA had no effect (P > 0.05). In long-term experiments, FOXO1 siRNA applied 6 and 12 weeks before the type 1 diabetic rats were killed reduced diabetes-enhanced FOXO1 nuclear translocation in microvascular cells by 86% (P < 0.05) (Fig. 2B). Scrambled siRNA had no effect (P > 0.05).
###end p 44
###begin p 45
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 594 595 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 608 609 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1022 1023 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1068 1069 1052 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1445 1446 1417 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1453 1454 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1558 1559 1530 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1562 1563 1534 1535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1673 1674 1645 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1769 1770 1739 1740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1849 1850 1819 1820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 160 164 <span type="species:ncbi:10116">rats</span>
###xml 284 288 <span type="species:ncbi:10116">rats</span>
###xml 290 292 <span type="species:ncbi:10116">DM</span>
###xml 353 357 <span type="species:ncbi:10116">rats</span>
###xml 384 386 <span type="species:ncbi:10116">DM</span>
###xml 422 424 <span type="species:ncbi:10116">DM</span>
###xml 517 521 <span type="species:ncbi:10116">rats</span>
###xml 727 731 <span type="species:ncbi:10116">rats</span>
###xml 733 735 <span type="species:ncbi:10116">DM</span>
###xml 809 813 <span type="species:ncbi:10116">rats</span>
###xml 840 842 <span type="species:ncbi:10116">DM</span>
###xml 876 878 <span type="species:ncbi:10116">DM</span>
###xml 1016 1020 <span type="species:ncbi:10116">rats</span>
###xml 1164 1168 <span type="species:ncbi:10116">rats</span>
###xml 1170 1172 <span type="species:ncbi:10116">DM</span>
###xml 1241 1245 <span type="species:ncbi:10116">rats</span>
###xml 1272 1274 <span type="species:ncbi:10116">DM</span>
###xml 1311 1313 <span type="species:ncbi:10116">DM</span>
###xml 1375 1379 <span type="species:ncbi:10116">rats</span>
###xml 1763 1767 <span type="species:ncbi:10116">rats</span>
FOXO1 siRNA effectively reduces FOXO1 mRNA level and nuclear translocation in vivo and reduces diabetes induced microvascular cell loss in STZ-induced diabetic rats. A: RNA was isolated from whole retinas and mRNA levels of FOXO1 determined by real-time PCR from STZ-induced diabetic rats (DM) that had been hyperglycemic for 12 weeks, matched diabetic rats treated with FOXO1 siRNA (DM + FOXO1 siRNA) or scrambled siRNA (DM + scrambled siRNA) for 10 days before euthanasia, and age-matched normoglycemic control (C) rats. Data represent mean relative fold change compared with control +/- SE (n = 5/group). B: The mean number of cells with clearly identified FOXO1 nuclear translocation was determined in STZ-induced diabetic rats (DM) that had been hyperglycemic for approximately6 months, matched diabetic rats treated with FOXO1 siRNA (DM + FOXO1 siRNA), scrambled siRNA (DM + scrambled siRNA) applied by two intravitreal injections at 12 and 6 weeks before euthanasia, and age-matched normoglycemic control (C) rats (n = 5/group). Data represent the mean +/- SE. C: The mean number of TUNEL-positive microvascular cells was determined in STZ-induced diabetic rats (DM) that had been diabetic for approximately6 months, matched diabetic rats treated with FOXO1 siRNA (DM + FOXO1 siRNA), or scrambled siRNA (DM + scrambled siRNA) and age-matched normoglycemic control (C) rats, by intravitreal injections at 12 and 6 weeks before euthanasia (n = 5). D: The mean number of pericyte ghosts was determined in PAS-stained RTDs from groups described above in (C). E: The mean number of acellular capillaries was determined in PAS-stained RTDs from groups described above in (C). Data represent the means +/- SE. *Significantly higher in diabetic than normoglycemic rats (P < 0.05). **Significantly less with FOXO1 siRNA compared with scrambled siRNA (P < 0.05).
###end p 45
###begin p 46
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 343 349 343 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 469 470 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 480 486 468 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 486 487 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 593 594 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 663 664 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 707 713 683 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 713 714 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 774 775 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 337 341 <span type="species:ncbi:10116">rats</span>
###xml 701 705 <span type="species:ncbi:10116">rats</span>
The role of FOXO1 in microvascular apoptosis and the cumulative effect of apoptosis as reflected by pericyte ghost formation and the development of acellular capillaries was examined (23). Type 1 diabetes increased the number of TUNEL-positive cells sevenfold, which was reduced 75% by FOXO1 siRNA (P < 0.05) in the STZ-induced diabetic rats (Fig. 2C). Diabetes induced a sixfold increase in pericyte ghost formation, which was reduced approximately75% by FOXO1 siRNA (P < 0.05) (Fig. 2D and supplemental Fig. 6). Similarly, type 1 diabetes increased acellular capillary formation by twofold (P < 0.05), and FOXO1 siRNA reduced this increase by approximately60% (P < 0.05) in the STZ-induced diabetic rats (Fig. 2E). For all three parameters, scrambled siRNA had no effect (P > 0.05).
###end p 46
###begin p 47
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 391 391 379 379 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="cjs2088.jpg" mimetype="image"/>
###xml 631 632 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 977 978 953 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1035 1036 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1108 1109 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1188 1189 1162 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 89 93 <span type="species:ncbi:10116">rats</span>
###xml 209 213 <span type="species:ncbi:10116">rats</span>
###xml 265 267 <span type="species:ncbi:10116">DM</span>
###xml 277 281 <span type="species:ncbi:10116">rats</span>
###xml 308 310 <span type="species:ncbi:10116">DM</span>
###xml 334 338 <span type="species:ncbi:10116">rats</span>
###xml 369 371 <span type="species:ncbi:10116">DM</span>
###xml 437 441 <span type="species:ncbi:10116">rats</span>
###xml 731 735 <span type="species:ncbi:10116">rats</span>
###xml 787 789 <span type="species:ncbi:10116">DM</span>
###xml 796 800 <span type="species:ncbi:10116">rats</span>
###xml 827 829 <span type="species:ncbi:10116">DM</span>
###xml 850 854 <span type="species:ncbi:10116">rats</span>
###xml 885 887 <span type="species:ncbi:10116">DM</span>
###xml 955 959 <span type="species:ncbi:10116">rats</span>
###xml 1102 1106 <span type="species:ncbi:10116">rats</span>
FOXO1 siRNA reduces retinal microvascular endothelial cell and pericyte apoptosis in ZDF rats. A: The mean number of cleaved caspase-3-positive endothelial cells and pericytes were determined in RTDs from ZDF rats that were hyperglycemic for approximately6 months (DM, ■), ZDF rats treated with FOXO1 siRNA (DM + FOXO1 siRNA, ▧), ZDF rats treated with scrambled siRNA (DM + scrambled siRNA, ), and from age-matched normoglycemic control rats (C, ▩), applied by an intravitreal injection 10 days before euthanasia. Pericytes and endothelial cells were determined by comparison of a bright field image of the same field PAS stained. B: The mean number of TUNEL-positive endothelial cells and pericytes were measured in RTDs from ZDF rats that were hyperglycemic for approximately6 months (DM), ZDF rats treated with FOXO1 siRNA (DM + FOXO1 siRNA), ZDF rats treated with scrambled siRNA (DM + scrambled siRNA), and from age-matched normoglycemic control (C) rats, as described in B. Each value represents the mean number per RTD +/- SE. (n = 6/group). *Significantly higher in diabetic than normoglycemic rats (P < 0.05). **Significantly less with FOXO1 siRNA compared with scrambled siRNA (P < 0.05).
###end p 47
###begin title 48
###xml 81 85 <span type="species:ncbi:10116">rats</span>
FOXO1 RNAi reduces microvascular cell apoptosis in the retina of type 2 diabetic rats.
###end title 48
###begin p 49
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 285 291 285 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 362 368 362 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 553 559 553 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 594 595 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The impact of silencing FOXO1 on microvascular cell apoptosis was assessed in retinal trypsin digests in type 2 diabetic animals. An 8-fold increase in retinal microvascular endothelial cells expressing activated caspase-3 caused by diabetes was reduced 74% by FOXO1 siRNA (P < 0.05) (Fig. 3A), and a 10-fold increase in pericytes was reduced by 80% (P < 0.05) (Fig. 3A). FOXO1 siRNA also reduced the fivefold increase in diabetes-enhanced TUNEL-positive endothelial cells by 79% and the fivefold increase in TUNEL-positive pericytes by 71% (P < 0.05) (Fig. 3B). Scrambled siRNA had no effect (P > 0.05). Representative images of caspase-3 and TUNEL-positive retinal microvascular endothelial cells are shown in supplemental Figs. 4 and 5. As an additional control, immunohistochemistry experiments were carried out with antibody to CD18, demonstrating that there were very few immune cells trapped within the microvasculature and none of these were apoptotic when immunohistochemistry with CD18 was combined with the TUNEL assay (data not shown).
###end p 49
###begin p 50
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 959 960 959 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 982 983 982 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1026 1029 1026 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">. E</italic>
###xml 1050 1051 1050 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
High glucose enhances FOXO1 DNA binding and decreases FOXO1 phosphorylation in the retinal microvascular endothelial cells in vitro, and FOXO1 siRNA reduces high glucose increased FOXO1 mRNA, protein, and apoptosis. A: RMECs were incubated in standard culture media (5 mmol/l glucose), media with high glucose (15-35 mmol/l), or media with 25 mmol/l mannitol for 5 days. Extracted nuclear proteins were tested for FOXO1 DNA binding activity by transcription factor ELISA. B: RMECs were incubated with standard media (C) or high-glucose media, 25 mmol/l (HG). Following treatment, total and phosphorylated FOXO1 levels were measured in cellulo. C: RMECs were transfected with FOXO1 siRNA or scrambled siRNA in vitro for 24 h. After transfection cells were incubated in standard media (5 mmol/l) or media with high glucose (25 mmol/l) for 5 days. mRNA levels of FOXO1 were determined by real-time PCR and normalized by the level of 18S rRNA in the same sample. D: cells treated as in C were assessed for FOXO1 protein in cellulo. E: Cells described in C were assayed for apoptosis by ELISA measuring cytoplasmic histone-associated DNA. Each value represents the mean +/- SE obtained from three independent experiments.
###end p 50
###begin title 51
High glucose stimulates FOXO1 DNA binding and modulates FOXO1 phosphorylation in RMECs in vitro, and high-glucose-stimulated apoptosis is reduced by FOXO1 silencing.
###end title 51
###begin p 52
###xml 191 192 191 192 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 240 246 240 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 573 579 573 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 667 668 667 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 731 732 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 742 748 742 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 748 749 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 875 876 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 886 892 886 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 892 893 892 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1171 1172 1171 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1182 1188 1182 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 1188 1189 1188 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
Incubation of RMECs with high glucose induced a dose-dependent increase in FOXO1 DNA binding that was increased 2.3-fold in 25 mmol/l glucose compared with standard glucose (5 mmol/l), while d-mannitol (25 mmol/l) had no effect (P > 0.05) (Fig. 4A), demonstrating that the effect is not due to osmotic shock. To establish whether high glucose altered FOXO1 protein and its phosphorylation status, assays were performed in cellulo. High glucose significantly increased total FOXO1 protein level twofold, while simultaneously reducing phosphorylated FOXO1 by 37% (P < 0.05) (Fig. 4B), consistent with FOXO1 activation. High glucose increased FOXO1 mRNA level 1.7-fold (P < 0.05), and transfection with FOXO1 siRNA reduced it by 61% (P < 0.05) (Fig. 4C). FOXO1 siRNA also reduced total FOXO1 protein levels in high-glucose-stimulated RMECs by 57% compared with scrambled siRNA (P < 0.05) (Fig. 4D), consistent with reports that siRNA achieves knockdown for 5 days in dividing cells and 3 weeks in nondividing cells (24). High glucose induced a 2.3-fold increase in RMEC apoptosis, and FOXO1 siRNA transfection resulted in 70% reduction in high-glucose-stimulated apoptosis (P < 0.05) (Fig. 4E).
###end p 52
###begin title 53
High glucose reduces phosphorylated AKT and FOXO1 levels in RMECs in vitro.
###end title 53
###begin p 54
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 121 127 121 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 333 339 333 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 339 340 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 398 404 398 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 404 405 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
Incubation in high glucose caused a 32% reduction (P < 0.05) in phosphorylated Akt without affecting AKT protein levels (Fig. 5A). The functional importance of Akt in FOXO1 was assessed by using an Akt inhibitor, which further reduced high-glucose-diminished FOXO1 phosphorylation by 52% compared with high glucose alone (P < 0.05) (Fig. 5B). The Akt inhibitor did not affect FOXO1 protein levels (Fig. 5C).
###end p 54
###begin p 55
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 324 325 324 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 526 527 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 719 720 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 991 992 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1069 1070 1068 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1245 1246 1240 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1457 1458 1448 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1688 1689 1679 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 1813 1814 1804 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 2080 2081 2071 2072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</italic>
###xml 2291 2292 2281 2282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 2439 2440 2427 2428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
High glucose modulates AKT and FOXO1 and high glucose induced apoptosis is mediated by TNF, ROS, FOXO1, and caspase-3 in retinal microvascular endothelial cells. A: RMECs were incubated with standard media (C) or high glucose (HG) for 5 days as described above and assayed for AKT protein and phosphorylated AKT in cellulo. B: RMECs were incubated with standard media (C; 5 mmol/l), high glucose (HG; 25 mmol/l), or high glucose with AKT inhibitor (HG + AKT inhibitor) for 5 days and assayed for phosphorylated FOXO1 protein. C: RMECs were incubated with standard media (C; 5 mmol/l), high glucose (HG; 25 mmol/l), or high glucose with AKT inhibitor (HG + AKT inhibitor) for 5 days and assayed for total FOXO1 protein. D: RMECs were incubated with standard media (C), high-glucose media, 25 mmol/l (HG), and high-glucose media plus 10 mug/ml pegsunercept (HG + Peg) for 5 days. Following treatment, extracted nuclear proteins were tested for FOXO1 DNA binding by transcription factor ELISA. E: RMECs were transfected with FOXO1 siRNA or scrambled siRNA as described in A and incubated with or without TNF-alpha (20 ng/ml) for 6 h. mRNA levels of FOXO1 were determined by real-time PCR and normalized by the level of 18S rRNA in the same sample. F: RMECs were transfected with FOXO1 siRNA or scrambled siRNA followed by stimulation with or without TNF-alpha (20 ng/ml) for 6 h. Apoptosis was determined by ELISA measuring histone-associated cytoplasmic DNA. G: RMECs were incubated with standard media (C; 5 mmol/l); high glucose (HG; 25 mmol/l); high glucose with NAC, a ROS inhibitor (10 mmol/l) (HG + NAC); and nuclear proteins were extracted and tested for FOXO1 DNA binding activity. H: Cells were incubated in standard media (C), high-glucose media (HG), or high glucose plus NAC (10 mmol/l) (HG + ROS Inh). I: RMECs were transfected with FOXO1 siRNA or scrambled siRNA in vitro for 24 h. After transfection cells were incubated in standard media (5 mmol/l) or media with high glucose (25 mmol/l) for 5 days. Caspase-3/-7 activity was measured using a luminescent substrate. J: RMECs were incubated with standard media (C; 5 mmol/l), high glucose (HG; 25 mmol/l), high glucose with caspase-3 inhibitor (10 mumol/l) (HG + Z-DEVD-FMK) for 5 days and assayed for apoptosis as described in F. Each value represents the mean of three independent experiments +/- SE. *Significantly different in high glucose compared with standard glucose (P < 0.05). **Significantly different in treated high glucose compared with untreated high glucose.
###end p 55
###begin title 56
TNF inhibition reduces high-glucose-induced FOXO1 DNA binding activity and high-glucose-induced FOXO1 DNA binding in a reactive oxygen species-dependent manner.
###end title 56
###begin p 57
###xml 64 70 64 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 205 211 205 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 301 302 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 342 348 338 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 348 349 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 411 412 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 422 428 414 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 428 429 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 694 700 686 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 700 701 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 794 800 786 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 800 801 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 938 939 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 949 955 941 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 955 956 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 1065 1066 1057 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1076 1082 1068 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1082 1083 1074 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</italic>
Both high glucose and TNF stimulate FOXO1 DNA binding activity (Fig. 5D and E). Moreover, TNF, in part, mediates high-glucose-stimulated FOXO1 DNA binding since pegsunercept reduces it by >42% (P < 0.05) (Fig. 5D). FOXO1 siRNA also reduced FOXO1 mRNA levels by 65% in RMECs stimulated with TNF-alpha (P < 0.05) compared with scrambled siRNA (Fig. 5E) and reduced TNF-alpha-stimulated apoptosis of RMECs by 64% (P < 0.05) (Fig. 5F). To identify the potential upstream and downstream mechanism, in vitro experiments with RMECs revealed that high-glucose-induced FOXO1 DNA binding returned to baseline levels when reactive oxygen species (ROS) inhibitor was used compared with high glucose alone (Fig. 5G). Under similar conditions, apoptosis was reduced by >61% when ROS formation was inhibited (Fig. 5H). High glucose also led to greater caspase-3/7 activation, and FOXO1 siRNA reduced high-glucose-induced caspase-3/7 activation by >50% (P < 0.05) (Fig. 5I). In addition, when a caspase-3/7 inhibitor was used, high-glucose-stimulated apoptosis was reduced by 50% (P < 0.05) (Fig. 5J). Thus, high glucose appears to induce RMECs apoptosis through a mechanism that involves reduced FOXO1 phosphorylation and increased FOXO1 mRNA, protein, and DNA binding activity. Furthermore, high-glucose-induced FOXO1 DNA binding activity or apoptosis is mediated by formation of ROS and TNF.
###end p 57
###begin title 58
FOXO1 regulates high-glucose-induced gene expression.
###end title 58
###begin p 59
###xml 495 502 495 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
To identify potential mechanisms through which FOXO1 may mediate the effects of hyperglycemia, mRNA profiling with focused microarrays was undertaken. The mean and median values of three microarrays per assay conditions are shown compared with the mean on the corresponding control with a threshold set at a minimum 1.7-fold increase or 0.58-fold decrease. The genes were divided into three functional groups regulating endothelial cell activation, endothelial cell apoptosis, and angiogenesis (Table 2). High glucose enhanced the mRNA levels of 10 of 14 genes (CCL2, CCL5, F3, ICAM1, IL6, PLAT, TFPI, TFPI2, THBD, and VCAM1) that modulate endothelial cell activation by 2.0- to 3.5-fold. FOXO1 siRNA reduced mRNA levels of all 14 genes belonging to this group by 0.12- to 0.58-fold. All eight genes (BCL2, CASP3, CASP6, TNF-alpha, TNFRSF11B, BCL2A1, BIRC3, and BIRC4) tested that are involved in apoptosis were increased by high glucose from 1.7- to 2.9-fold. FOXO1 siRNA reduced mRNA levels of five (BCL2, CASP3, CASP6, TNF-alpha, and TNFRSF11B) of these from 0.34- to 0.45-fold.
###end p 59
###begin p 60
Genes regulated by high glucose or high glucose plus FOXO1 siRNA in RMECs
###end p 60
###begin p 61
Data are mean and median of three independent arrays for each time point. Boldface indicates that both the mean and median of the experimental group was 1.7- or 0.58-fold of the corresponding control (high glucose versus low glucose; high glucose plus FOXO1 siRNA versus high glucose plus scrambled siRNA). RMECs were incubated with or without high glucose (25 mmol/l) for 5 days. Some cells were transfected with FOXO1 siRNA or scrambled siRNA for 24 h prior to incubation in high glucose for 5 days. Total RNA was isolated and subjected to focused microarray analysis. The table lists genes differentially regulated by high glucose or FOXO1 siRNA in high-glucose-treated microvascular endothelial cells. High glucose: fold change in mRNA level in high-glucose-treated cells versus standard-glucose-treated cells. High glucose plus FOXO1 siRNA: fold change in mRNA level of each gene in cells transfected with FOXO1 siRNA plus high glucose versus scrambled siRNA plus high glucose.
###end p 61
###begin p 62
###xml 101 108 101 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 473 479 473 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
The majority of genes involved in angiogenesis were not modulated by high glucose but were by FOXO1 (Table 2). High glucose stimulated an increase in mRNA levels of 4 (ITGB1, ANGPT1, FLT4, and VEGF) of 10 of these genes from 2.6- to 4.9-fold. FOXO1 siRNA reduced mRNA of these four as well as others (ITGA5, ITGAV-M, ITGB3, KDR, and TEK) by 0.29- to 0.54-fold. Genes from each functional category were selected and results with microarrays were confirmed by real-time PCR (Fig. 6). For CASP-3, ICAM1, VEGF, and TNF-alpha, stimulation with high glucose induced a minimum 1.7-fold increase and inhibition by FOXO1-induced a 0.58-fold decrease whether assayed by microarray or by real-time PCR.
###end p 62
###begin p 63
###xml 463 470 459 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 695 697 691 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 804 806 800 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 890 892 886 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
Comparison of mRNA levels obtained by microarray or real-time PCR. RMECs were transfected with FOXO1 siRNA or scrambled siRNA in vitro for 24 h, transferred to standard media (5 mmol/l) or high-glucose media (25 mmol/l) for 5 days. mRNA levels of CASP3, ICAM1, VEGF-A, and TNF-alpha were determined by real-ime PCR and normalized by the level of 18S rRNA in the same sample. Microarray analysis of the same treatment groups are also shown from values obtained in Table 2. Data presented is the fold change between each experimental group and its control (high glucose compared with standard glucose; FOXO1 siRNA plus HG compared with scrambled siRNA plus HG. The fold change was converted to log10 scale to facilitate comparison between different genes. The horizontal solid line corresponds to 0.23 (log10 equivalent of 1.7 upregulation threshold) and dashed line corresponds to -0.23 (log10 equivalent of 1.7 fold downregulation threshold). ■, microarray high glucose; ▩, microarray HG + FOXO1 siRNA; ▧, quantitative RT-PCR high glucose; square, quantitative RT-PCR HG + FOXO1 siRNA.
###end p 63
###begin title 64
DISCUSSION
###end title 64
###begin p 65
###xml 654 658 <span type="species:ncbi:10116">rats</span>
We report for the first time that diabetes increases FOXO1 mRNA levels and DNA binding activity in the retina. In addition, both type 1 and type 2 diabetic models exhibited increased FOXO1 nuclear translocation in retinal microvascular cells. These increases occurred in a time frame when increased inflammation, caspase-3-positive cells, and enhanced apoptosis are present (8-26 weeks). Moreover, TNF-mediated diabetes enhanced FOXO1 mRNA levels, DNA binding, and nuclear translocation. Thus, we propose that diabetes increases TNF-alpha, which enhances FOXO1 mRNA levels, nuclear translocation, and DNA binding in retinas of type 1 and type 2 diabetic rats.
###end p 65
###begin p 66
###xml 380 384 <span type="species:ncbi:10116">rats</span>
###xml 578 582 <span type="species:ncbi:10116">rats</span>
The functional significance of FOXO1 was tested by RNAi. Intravitreal injection of FOXO1 siRNA significantly reduced FOXO1 mRNA levels and FOXO1 nuclear translocation, while control-scrambled siRNA had no effect. The effect of FOXO1 knockdown by siRNA was evident 6 weeks after the second injection, indicating that silencing is effective for at least 6 weeks. In type 1 diabetic rats, FOXO1 siRNA significantly decreased microvascular cell apoptosis, the formation of pericyte ghosts, and the development of acellular capillaries. Similar results were found in type 2 diabetic rats. FOXO1 siRNA significantly reduced cleaved caspase-3- and TUNEL-positive pericytes and endothelial cells. This represents the first demonstration that FOXO1 plays a critical role in diabetes-induced apoptosis and retinal microvascular cell loss.
###end p 66
###begin p 67
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
In retinal microvascular endothelial cells, high glucose was shown to increase FOXO1 mRNA and protein levels. In addition, high glucose reduced FOXO1 phosphorylation, consistent with increased DNA binding activity, since FOXO1 is deactivated by phosphorylation. High glucose did not affect total Akt levels but did significantly decrease the active phosphorylated isoforms of Akt. When Akt was inhibited there was a further decrease in FOXO1 phosphorylation, indicating that high glucose levels could modulate FOXO1 through its effect on Akt. In addition, hypoinsulinemia or insulin resistance associated with diabetes could potentially contribute to decreased phosphorylation of Akt in vivo and contribute to enhanced FOXO1 activity (25).
###end p 67
###begin p 68
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
As discussed above, TNF-mediated diabetes enhanced FOXO1 activation both in vitro and in vivo. Furthermore, TNF stimulated apoptosis that was reduced by FOXO1 siRNA. Similarly, ROS inhibitor reduced high-glucose-stimulated FOXO1 DNA binding activity and high-glucose-induced apoptosis. Also, high-glucose-stimulated apoptosis was inhibited by FOXO1 siRNA. Thus, several pathways by which high glucose increased FOXO1 were tested. In each case, the factor was shown to mediate high-glucose-stimulated apoptosis of retinal endothelial cells. The results obtained in vitro and in vivo are strikingly similar and indicate that hyperglycemia per se could stimulate apoptosis of microvascular cells through a mechanism not involving other cell types, although it cannot be ruled out that other cell types or leukostasis in the retina may play an important role in the apoptotic process (26,27).
###end p 68
###begin p 69
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 607 607 607 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29"/>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1556 1558 1556 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1780 1782 1780 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1851 1853 1851 1853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 2039 2041 2035 2037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 2042 2044 2038 2040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
In vitro mRNA profiling suggests that FOXO1 mediates high-glucose-induced mRNA expression of genes that modulate endothelial cell activation and apoptosis and the basal expression of genes that affect angiogenesis, which were not altered by high-glucose conditions. A surprising finding was that FOXO1 siRNA reduced mRNA levels of several genes that regulate proinflammatory and procoagulant responses. Thus, FOXO1 could induce expression of genes that participate in the very early events that affect diabetic retinal microvascular endothelial cells, many of which are known to be increased by diabetes (28-30). This is significant since it has not previously been recognized that FOXO1 could modulate proinflammatory gene expression. However, it is consistent with activation of FOXO1 during the early inflammatory phase of diabetic retinopathy. In addition, FOXO1 siRNA modulated a high percentage of proapoptotic genes, consistent with its known proapoptotic function (20). This is supported by data reported here that FOXO1 siRNA inhibited high-glucose-stimulated caspase-3 activity and apoptosis in microvascular endothelial cells in vitro. Furthermore, inhibition of caspase-3 blocked high-glucose-stimulated apoptosis, consistent with FOXO1-regulated caspase-3 mRNA levels and caspase-3 activity. Last, mRNA expression of genes associated with angiogenesis were also enhanced by high glucose and/or reduced by FOXO1 siRNA. This is consistent with a report that FOXO1 overexpression induces genes that regulate angiogenesis and vascular remodeling (31). Thus, high glucose and FOXO1 had a dramatic effect on genes that regulate a relatively diverse array of genes that modulate endothelial cell behavior, several of which are thought to contribute to diabetic retinopathy (30). FOXO1 can affect gene expression without directly binding to DNA (32). For example, FOXO1 can regulate transcription by enhancing the activity of CCAAT/enhancer binding protein alpha or by modulating the DNA binding and transcriptional activity of PAX3 (33,34).
###end p 69
###begin p 70
###xml 174 180 <span type="species:ncbi:9606">humans</span>
Few studies have examined the role of transcription factors in early diabetic retinopathy, and a limitation of our studies is that it is unknown if these findings pertain to humans with diabetes. Findings from the short-term application of FOXO1 RNAi point to the possibility of using long-term inhibition of FOXO1 by shRNA in diabetic retinopathy. Moreover, FOXO1 may potentially play an important role in other diabetes complications, where locally enhanced inflammation and apoptosis are associated with pathologic changes. In summary, studies presented here demonstrate a mechanistic link between diabetes, enhanced TNF-alpha levels in the retina, increased FOXO1 nuclear translocation, and microvascular cell apoptosis. This provides a basis for understanding how chronic low-grade inflammation may play a role in early diabetic retinopathy.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
Online-Only Appendix
###end title 72
###begin p 73
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 73
###begin title 74
Acknowledgments
###end title 74
###begin p 75
###xml 164 169 <span type="species:ncbi:9689">Lions</span>
This study was supported by National Institutes of Health Grants R01DE17732, R01DE07559, and R01EY014702 and in part by a departmental grant from the Massachusetts Lions Eye Research Organization.
###end p 75
###begin p 76
No potential conflicts of interest relevant to this article were reported.
###end p 76
###begin title 77
REFERENCES
###end title 77
###begin article-title 78
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
###end article-title 78
###begin article-title 79
Retinopathy in diabetes.
###end article-title 79
###begin article-title 80
###xml 52 57 <span type="species:ncbi:9606">human</span>
Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.
###end article-title 80
###begin article-title 81
Pericytes and the pathogenesis of diabetic retinopathy.
###end article-title 81
###begin article-title 82
Glucose, VEGF-A, and diabetic complications.
###end article-title 82
###begin article-title 83
Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina.
###end article-title 83
###begin article-title 84
Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.
###end article-title 84
###begin article-title 85
Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin.
###end article-title 85
###begin article-title 86
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.
###end article-title 86
###begin article-title 87
FOXO transcription factors in cell-cycle regulation and the response to oxidative stress.
###end article-title 87
###begin article-title 88
Cell cycle and death control: long live Forkheads.
###end article-title 88
###begin article-title 89
Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.
###end article-title 89
###begin article-title 90
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization.
###end article-title 90
###begin article-title 91
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
###end article-title 91
###begin article-title 92
The forkhead transcription factor Foxo1 regulates adipocyte differentiation.
###end article-title 92
###begin article-title 93
Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.
###end article-title 93
###begin article-title 94
Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability.
###end article-title 94
###begin article-title 95
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases.
###end article-title 95
###begin article-title 96
###xml 103 106 <span type="species:ncbi:10116">rat</span>
Proliferative effect of high glucose is modulated by antisense oligonucleotides against fibronectin in rat endothelial cells.
###end article-title 96
###begin article-title 97
FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis.
###end article-title 97
###begin article-title 98
Lipopolysaccharides indirectly stimulate apoptosis and global induction of apoptotic genes in fibroblasts.
###end article-title 98
###begin article-title 99
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging.
###end article-title 99
###begin article-title 100
###xml 131 135 <span type="species:ncbi:10116">rats</span>
Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats.
###end article-title 100
###begin article-title 101
Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
###end article-title 101
###begin article-title 102
Diabetes outfoxed by GLP-1?
###end article-title 102
###begin article-title 103
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
The Ins2Akita mouse as a model of early retinal complications in diabetes.
###end article-title 103
###begin article-title 104
Oxidative stress and diabetic retinopathy.
###end article-title 104
###begin article-title 105
Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations.
###end article-title 105
###begin article-title 106
###xml 120 123 <span type="species:ncbi:10116">rat</span>
An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
###end article-title 106
###begin article-title 107
Early cellular and molecular changes induced by diabetes in the retina.
###end article-title 107
###begin article-title 108
Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1).
###end article-title 108
###begin article-title 109
FOXO-binding partners: it takes two to tango.
###end article-title 109
###begin article-title 110
FOXO1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development.
###end article-title 110
###begin article-title 111
Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain.
###end article-title 111

